Prominent release of lipoxygenase generated mediators in a murine house dust mite-induced asthma model

Prostaglandins Other Lipid Mediat. 2018 Jul:137:20-29. doi: 10.1016/j.prostaglandins.2018.05.005. Epub 2018 May 12.

Abstract

The profile of activation of lipid mediator (LM) pathways in asthmatic airway inflammation remains unclear. This experimental study quantified metabolite levels of ω3-, ω6- and ω9-derived polyunsaturated fatty acids in bronchoalveolar lavage fluid (BALF) after 4-weeks of repeated house dust mite (HDM) exposure in a murine (C57BL/6) asthma model. The challenge induced airway hyperresponsiveness, pulmonary eosinophil infiltration, but with low and unchanged mast cell numbers. Of the 112 screened LMs, 26 were increased between 2 to >25-fold in BALF with HDM treatment (p < 0.05, false discovery rate = 5%). While cysteinyl-leukotrienes were the most abundant metabolites at baseline, their levels did not increase after HDM treatment, whereas elevation of PGD2, LTB4 and multiple 12/15-lipoxygenase products, such as 5,15-DiHETE, 15-HEDE and 15-HEPE were observed. We conclude that this model has identified a global lipoxygenase activation signature, not linked to mast cells, but with aspects that mimic chronic allergic airway inflammation in asthma.

Keywords: Airway hyperresponsiveness; BALF; HDM; Lipid mediators; PUFA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonate 12-Lipoxygenase / immunology*
  • Arachidonate 15-Lipoxygenase / immunology*
  • Arachidonate 5-Lipoxygenase / immunology*
  • Asthma / immunology*
  • Asthma / pathology
  • Bronchoalveolar Lavage
  • Disease Models, Animal
  • Inflammation Mediators / immunology*
  • Mice
  • Mice, Transgenic
  • Prostaglandins / immunology*
  • Pyroglyphidae / immunology*

Substances

  • 12-15-lipoxygenase
  • Inflammation Mediators
  • Prostaglandins
  • Arachidonate 12-Lipoxygenase
  • Arachidonate 15-Lipoxygenase
  • Arachidonate 5-Lipoxygenase